These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 18363591

  • 1. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E, Kralikova P.
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [Abstract] [Full Text] [Related]

  • 2. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A, Pipi E, Soufleros K.
    Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
    [Abstract] [Full Text] [Related]

  • 3. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC, Zhou B, Dong Y.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
    [Abstract] [Full Text] [Related]

  • 4. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 13; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 5. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 13; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 6. Clinical value of autoantibodies against C1q in children with glomerulonephritis.
    Kozyro I, Perahud I, Sadallah S, Sukalo A, Titov L, Schifferli J, Trendelenburg M.
    Pediatrics; 2006 May 13; 117(5):1663-8. PubMed ID: 16651321
    [Abstract] [Full Text] [Related]

  • 7. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
    Bigler C, Hopfer H, Danner D, Schaller M, Mihatsch MJ, Trendelenburg M.
    Nephrol Dial Transplant; 2011 Apr 13; 26(4):1220-8. PubMed ID: 20841491
    [Abstract] [Full Text] [Related]

  • 8. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y, Yang XW, Song Y, Yu F, Zhao MH.
    Immunobiology; 2014 Dec 13; 219(12):980-9. PubMed ID: 25092568
    [Abstract] [Full Text] [Related]

  • 9. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun 13; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 10. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov 13; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 11. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 12. C1q and systemic lupus erythematosus.
    Walport MJ, Davies KA, Botto M.
    Immunobiology; 1998 Aug 02; 199(2):265-85. PubMed ID: 9777411
    [Abstract] [Full Text] [Related]

  • 13. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus.
    Moura CG, Mangueira CL, Cruz LA, Cruz CM.
    Nephron Clin Pract; 2011 Aug 02; 118(4):c355-60. PubMed ID: 21325866
    [Abstract] [Full Text] [Related]

  • 14. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
    Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, Li Vecchi M, Messa P, Sinico RA.
    Ann Rheum Dis; 2009 Feb 02; 68(2):234-7. PubMed ID: 18718989
    [Abstract] [Full Text] [Related]

  • 15. Anti-C1q autoantibodies in lupus nephritis.
    Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G.
    Ann N Y Acad Sci; 2009 Sep 02; 1173():47-51. PubMed ID: 19758131
    [Abstract] [Full Text] [Related]

  • 16. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C, Schaller M, Perahud I, Osthoff M, Trendelenburg M.
    J Immunol; 2009 Sep 01; 183(5):3512-21. PubMed ID: 19648280
    [Abstract] [Full Text] [Related]

  • 17. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E, Tănăsescu C, Bălănescu P, Olteanu R, Badea C, Petruţescu B, Grancea C, Vagu C, Bleotu C, Ruţă S, Ardeleanu C.
    Rom J Intern Med; 2010 Sep 01; 48(2):159-63. PubMed ID: 21428180
    [Abstract] [Full Text] [Related]

  • 18. [Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example].
    Trendelenburg M, Schifferli JA.
    Praxis (Bern 1994); 1998 Dec 24; 87(51-52):1811-3. PubMed ID: 10025155
    [Abstract] [Full Text] [Related]

  • 19. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C, Olin AI, Skogh T, Wetterö J, Mörgelin M, Nived O, Sturfelt G, Bengtsson AA.
    Autoimmunity; 2013 May 24; 46(3):205-14. PubMed ID: 23331132
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis.
    Yin Y, Wu X, Shan G, Zhang X.
    Lupus; 2012 Sep 24; 21(10):1088-97. PubMed ID: 22777943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.